Cancer survival gains are set to reverse because of staff shortages, MPs warn
BMJ 2022; 377 doi: https://doi.org/10.1136/bmj.o893 (Published 05 April 2022) Cite this as: BMJ 2022;377:o893- Adrian O’Dowd
- London
Urgent steps are needed to prevent the UK from losing gains made in recent years on cancer survival rates and to halt a predicted rise in unnecessary cancer deaths because of delayed diagnosis and treatment, an influential parliamentary committee has said.
The Health and Social Care Committee published its report on cancer services on 5 April,1 in which it criticised the government for its lack of “serious effort” on improving cancer workforce shortages.
Evidence provided to the committee by the government and the NHS demonstrated that the NHS was not on track to meet its target on early cancer diagnosis—namely, the NHS Long Term Plan’s target to diagnose 75% of cancers at stage I or II by 2028. The …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.